Smoking boosts clopidogrel effect in people with diabetes and CAD

04/9/2012 | Medscape (free registration)

Data on 134 patients with type 2 diabetes and coronary artery disease who were on maintenance clopidogrel therapy showed that those who smoked were less likely to suffer from high on-treatment platelet reactivity than nonsmokers. However, researchers warned that cardiovascular events, including mortality, remained higher for smokers. The results were published in JACC: Cardiovascular Interventions.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care